新型CryoPop®冷冻治疗设备在低中收入国家治疗宫颈异型增生的安全性与有效性:多中心开放标签非劣效临床试验(含历史对照)的研究方案
本研究在印度卡纳塔克邦北部四个中心开展,采用醋酸肉眼观察(VIA)筛查,对确诊高级别宫颈异型增生(HSIL)且符合全部入选标准者,使用新型冷冻治疗设备CryoPop®进行治疗。研究设计为多中心开放标签非劣效临床试验,以历史对照为比较,旨在评估该设备的安全性与有效性。研究强调需要开发低成本、简单、有效的冷冻治疗设备,以便基层卫生人员在筛查同时提供及时治疗。
要点
- 研究在印度卡纳塔克邦北部四中心开展,采用VIA筛查并转诊阴道镜及定向活检。
- 确诊HSIL且符合全部入选标准者接受CryoPop®冷冻治疗。
- 设计为多中心开放标签非劣效临床试验,对照为历史对照。
核心结论
- 研究旨在评估CryoPop®冷冻治疗设备在低中收入国家治疗宫颈高级别异型增生的安全性与有效性,以历史对照作非劣效比较。
研究设计与样本
- 多中心开放标签非劣效临床试验,设历史对照;在印度卡纳塔克邦北部四个中心开展。
- 经醋酸肉眼观察(VIA)筛查阳性者转诊至研究医院行阴道镜及定向活检,确诊高级别宫颈异型增生(HSIL)且符合全部其他入选标准者被招募并接受CryoPop®冷冻治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cervical cancer is the fourth most common cancer in the world, affecting mainly women residing in low- and middle-income countries. Progression from a pre-invasive phase to that of an invasive phase generally takes years and provides a window of opportunity to screen for and treat precancerous lesions. METHODS: This study is being conducted at four sites in north Karnataka, India. Community sensitization activities have been organized in the study areas to create awareness among stakeholders, including elected representatives, physicians, health care workers, and potential participants. Organized community based as well as hospital-based screening is being conducted using visual inspection with acetic acid (VIA). Screen positive women are referred to respective study hospitals for colposcopy and directed biopsy. Participants with confirmed high-grade cervical dysplasia (high-grade squamous intraepithelial lesions or HSIL) who fit all other eligibility criteria will be recruited to the study and will receive cryotherapy using CryoPop®, an innovative new cryotherapy device. DISCUSSION: There is a need to develop an inexpensive, simple, and effective cryotherapy device for use by frontline health care providers at locations where screening and timely treatment can be given, accelerating access to cervical cancer prevention services and minimizing loss to follow-up of women with precancerous lesions who need treatment. TRIAL REGISTRATION: Clinical Trial Registry - India CTRI/2019/01/017289 ClinicalTrials.Gov number NCT04154644 . Registered on November 6, 2019.
引用
- Yogeshkumar S, Anderson J, Lu E, et al. Safety and efficacy of the new CryoPop® cryotherapy device for cervical dysplasia in low- and middle-income countries: study protocol for a multicenter open-label non-inferiority clinical trial with historical controls. Trials. 2021. PMID: 34903244. doi:10.1186/s13063-021-05802-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。